Search Within

Solid Tumor Oncology Division

Formats
  1. Journal Article (10931)
  2. Meeting Abstract (9499)
  3. Review (556)
  4. Book Section (417)
  5. Editorial (336)
  6. Guidelines (158)
  7. Correspondence (118)
  8. Conference Paper (107)
  9. Research Letter (61)
  10. Miscellaneous (54)
  11. Book Whole (27)
Groups
  1. Department of Medicine (22241)
  2. GSK Faculty (5929)
  3. Genitourinary Oncology Service (5650)
  4. Survivorship Research (5226)
  5. Gastrointestinal Oncology Service (4692)
  6. Breast Medicine Service (4155)

More Groups

People
  1. Robert Motzer (1247)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (872)
  6. Leonard Saltz (792)

More People

Years
  1. 2025 (641)
  2. 2024 (1388)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1536)

More Years

Publications
  1. Journal of Clinical Oncology (5288)
  2. Annals of Oncology (1297)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (776)
  5. Journal of Thoracic Oncology (532)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5580)
  2. Elsevier Inc. (2662)
  3. American Association for Cancer Research (2327)
  4. Oxford University Press (1819)
  5. Nature Publishing Group (1043)
  6. Springer (981)

More Publishers

Results (22264)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IK-175, an oral AHR inhibitor, as monotherapy and in combination with nivolumab in patients with urothelial carcinoma resistant/refractory to PD-1/L1 inhibitors
    Meeting Abstract

    Aggen, D. H.; McKean, M.; Hoffman-Censits, J. H.; Lakhani, N. J.; Alhalabi, O.; Guancial, E. A.; Bashir, B.; Bowman, I. A.; Tan, A.; Lingaraj, T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 3, randomized study of adjuvant rilvegostomig plus chemotherapy in resected biliary tract cancer: ARTEMIDE-Biliary01
    Meeting Abstract

    Fan, J.; Bekaii-Saab, T. S.; Aldrighetti, L. A.; Bridgewater, J. A.; Ferrone, C. R.; Harding, J. J.; Ikeda, M.; Knox, J. J.; Wang, J. L.; Kayhanian, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Comparative patient-reported tolerability (PRT): A multiplicity-controlled analysis of LIBRETTO-531, a randomized controlled trial (RCT) in medullary thyroid cancer (MTC)
    Meeting Abstract

    Brose, M. S.; Robinson, B.; Wirth, L. J.; Capdevila, J.; Wadsley, J.; Sherman, E. J.; Tahara, M.; Hoff, A.; Hu, M. I. N.; Gao, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Health-related quality of life and pain in a phase 3 study of [(177)Lu] Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
    Meeting Abstract

    Fizazi, K.; Morris, M. J.; Shore, N. D.; Chi, K. N.; Crosby, M.; De Bono, J. S.; Herrmann, K.; Roubaud, G.; Nagarajah, J.; Fleming, M. T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: Results from the phase 3 MOTION trial
    Meeting Abstract

    Tap, W. D.; Bhadri, V.; Stacchiotti, S.; Bauer, S.; Wagner, A. J.; de Sande, M. V.; Bernthal, N. M.; Pousa, A. L.; Razak, A. R. A.; Italiano, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: Updated results
    Meeting Abstract

    Ho, A. L.; Nabell, L.; Neupane, P. C.; Posner, M. R.; Yilmaz, E.; Niu, J.; Naqash, A. R.; Pearson, A. T.; Wong, S. J.; Nieva, J. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Results from the bladder cohort of the DESTINY-PanTumor02 (DP-02) study
    Meeting Abstract

    Wysocki, P. J.; Jung, K. H.; Oh, D. Y.; Doroshow, D. B.; Artamonova, E.; Mammatas, L.; Su, P. J.; Moiseyenko, V.; Penkov, K.; Stroyakovskiy, D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Pooled analysis by best confirmed response to trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ metastatic breast cancer (mBC) from DESTINY-Breast-01,-02, and-03
    Meeting Abstract

    Saura, C.; CorteĢs, J.; Modi, S.; Kim, S. B.; Hamilton, E. P.; Hurvitz, S. A.; Krop, I. E.; Curigliano, G.; Iwata, H.; Im, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Lete-cel in patients with synovial sarcoma or myxoid/round cell liposarcoma: Planned interim analysis of the pivotal IGNYTE-ESO trial
    Meeting Abstract

    D'Angelo, S. P.; Furness, A. J. S.; Thistlethwaite, F.; Burgess, M. A.; Riedel, R. F.; Haanen, J.; Noujaim, J.; Chalmers, A. W.; Pousa, Alpo; Chugh, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • GEMINI-Hepatobiliary: A phase 2 study of novel first-line immuno-oncology-based treatments in patients with advanced hepatobiliary cancers
    Meeting Abstract

    Zhou, J.; Cheng, A. L.; Ikeda, M.; Lim, H. Y.; Akce, M.; Qin, S.; Oh, D. Y.; Chan, S. L.; Xiang, J.; Qu, X.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save